# Illumina, Inc. (ILMN) stock: price and valuation

URL: https://funkfolio.com/stock/ILMN

> Illumina, Inc. (ILMN) trades at $201.29, is worth $30.38B, is priced at 34.6× earnings and scores 59/100. Valuation, financials and signals.

---

## Illumina, Inc. (ILMN)

Illumina, Inc. (ILMN) is a healthcare company (diagnostics & research) based in the United States. The share price is $201.29, up 1.66% on the day, which values the company at $30.38B. Price as of 17 Nov 2026, 17:37 UTC, from Yahoo Finance.

### Key facts

- **Share price:** $201.29 +1.66% today
- **Market value:** $30.38B
- **P/E ratio:** 34.6× last 12 months
- **Forward P/E:** 32.5×
- **Funk Score:** 59/100
- **Against its own history:** Below its usual price usual price $282.76
- **200-week average:** $142.46 41% above
- **Sector:** Healthcare

Figures as of 17 Nov 2026, 17:37 UTC. Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

### Illumina, Inc. in more detail

ILMN trades at 34.6× its last twelve months' earnings, 32.5× next year's expected earnings, 6.7× sales. Measured against its own history, the price is 29% below what its usual multiples would imply ($282.76) — below its usual price. It sits 41% above its 200-week average of $142.46.

Its Funk Score is 59 out of 100 (financial strength 7.3, profitability 8.0, growth 2.4, value 6.0, each out of 10).

In its favour: Altman Z in the safe zone; Strong Piotroski score. Worth checking: Revenue is shrinking.

11 of the superinvestors tracked here hold ILMN, including Keith Meister (15.5% of the portfolio), Richard Mashaal (6.3% of the portfolio), Zach Schreiber (2.7% of the portfolio).

### Superinvestors holding ILMN

11 of the investors tracked here report a position in their latest 13F filing.

- [Keith Meister Corvex Management](https://funkfolio.com/gurus/keith-meister) 15.5% of portfolio · $497.7M · trimmed · Q2 2026
- [Richard Mashaal Senvest Management](https://funkfolio.com/gurus/richard-mashaal) 6.31% of portfolio · $218M · trimmed · Q3 2026
- [Zach Schreiber PointState Capital](https://funkfolio.com/gurus/zach-schreiber) 2.67% of portfolio · $151.6M · added · Q2 2026
- [Cathie Wood ARK Invest](https://funkfolio.com/gurus/cathie-wood) 1.34% of portfolio · $233.1M · trimmed · Q3 2026
- [Primecap team Primecap Management](https://funkfolio.com/gurus/primecap) 0.59% of portfolio · $955.4M · trimmed · Q3 2026
- [Diamond Hill team Diamond Hill Capital Management](https://funkfolio.com/gurus/diamond-hill) 0.40% of portfolio · $37.1M · trimmed · Q3 2026
- [Baillie Gifford team Baillie Gifford & Co](https://funkfolio.com/gurus/baillie-gifford) 0.33% of portfolio · $345.4M · trimmed · Q3 2026
- [Jim Simons (1938–2024) Renaissance Technologies](https://funkfolio.com/gurus/jim-simons) 0.25% of portfolio · $180.2M · trimmed · Q3 2026
- [Cliff Asness AQR Capital Management](https://funkfolio.com/gurus/cliff-asness) 0.22% of portfolio · $623.2M · trimmed · Q2 2026
- [Joel Greenblatt Gotham Asset Management](https://funkfolio.com/gurus/joel-greenblatt) 0.15% of portfolio · $62.6M · added · Q2 2026
- [Ron Baron Baron Capital (BAMCO)](https://funkfolio.com/gurus/ron-baron) 0.10% of portfolio · $58.5M · trimmed · Q3 2026

### Health Care companies of similar size

- [Biogen BIIB](https://funkfolio.com/stock/BIIB)
- [GE HealthCare Technologies GEHC](https://funkfolio.com/stock/GEHC)
- [Alcon ALC](https://funkfolio.com/stock/ALC)
- [Mettler-Toledo International MTD](https://funkfolio.com/stock/MTD)
- [Centene CNC](https://funkfolio.com/stock/CNC)
- [Genmab GMAB](https://funkfolio.com/stock/GMAB)
- [ResMed RMD](https://funkfolio.com/stock/RMD)
- [Zoetis ZTS](https://funkfolio.com/stock/ZTS)
- [Labcorp Holdings LH](https://funkfolio.com/stock/LH)
- [DexCom DXCM](https://funkfolio.com/stock/DXCM)
- [Koninklijke Philips PHG](https://funkfolio.com/stock/PHG)
- [Roivant Sciences ROIV](https://funkfolio.com/stock/ROIV)

Side by side: [ILMN vs RMD (Illumina, Inc. vs ResMed)](https://funkfolio.com/compare/ilmn-vs-rmd) [ILMN vs GMAB (Illumina, Inc. vs Genmab)](https://funkfolio.com/compare/gmab-vs-ilmn) [ILMN vs ZTS (Illumina, Inc. vs Zoetis)](https://funkfolio.com/compare/ilmn-vs-zts) [ILMN vs CNC (Illumina, Inc. vs Centene)](https://funkfolio.com/compare/cnc-vs-ilmn) [ILMN vs MTD (Illumina, Inc. vs Mettler-Toledo International)](https://funkfolio.com/compare/ilmn-vs-mtd)

[All health care companies by market value](https://funkfolio.com/companies/sector/health-care) [Largest companies in the United States](https://funkfolio.com/companies/country/united-states) [All stocks A–Z](https://funkfolio.com/stocks)

### Illumina, Inc. (ILMN): questions and answers

**What is ILMN's P/E ratio?**

Illumina, Inc. trades at 34.6× its last twelve months' earnings and 32.5× next year's expected earnings. At its fiscal year-ends over the past 15 years the P/E ranged from 24.1× to 122.9×, with a median of 53.9×.

**What is ILMN's PEG ratio?**

Illumina, Inc.'s PEG ratio is 2.55 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

**What is Illumina, Inc.'s market cap?**

Illumina, Inc. is valued at $30.38B at a share price of $201.29.

**Is ILMN overvalued or undervalued?**

Against its own history, ILMN is below its usual price: the price is 29% below the $282.76 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

**Is ILMN above its 200-week moving average?**

Yes. ILMN is 41.3% above its 200-week average of $142.46. Long-term investors watch that line because strong companies rarely trade below it for long.

**How fast is Illumina, Inc. growing?**

Over the last three fiscal years Illumina, Inc.'s revenue grew -1.4% a year and its earnings per share 3.6% a year.

### Learn to read these numbers

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “Illumina, Inc. (ILMN) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ILMN

Underlying data: Yahoo Finance; company filings with the SEC.
